



New 2026 guidelines from the American Heart Association and American College of Cardiology recommend screening for high cholesterol starting at age 9 and lean more heavily on newer markers like ApoB and lipoprotein A alongside standard LDL and HDL tests.
The guidelines also promote a risk calculator called PREVENT-ASCVD and recommend coronary artery calcium scans in some cases, aiming to tailor statin and other drug treatment to each patient's individual risk rather than one-size-fits-all thresholds.
Statins remain the backbone of treatment, with newer drug classes available for patients who need more or can't tolerate statins.
The full dispatch is available from the source below.